Aranding, Ayro A.

HRN: 25-38-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2025
AMPICILLIN 500MG (VIAL)
12/24/2025
12/31/2025
IV
400mg
Q6H
PCAP C
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines